Aimed at improving patient outcomes and increasing connectivity for more efficient monitoring In hospitals and homes
Efgartigimod is approved in the United States as VYVGART for the treatment of adults with generalized myasthenia gravis
NDM disorders are a group of rare, inherited neuromuscular disorders which is characterized by the inability to relax muscles following voluntary contraction
Proprietary implant-to-implant (i2i) device technology is used for communication between two implanted leadless pacemakers to regulate the heart rate
The recommended daily dose for Ryaltris is 2 sprays in each nostril twice daily
Ryaltris is a fixed dose combination nasal spray that combines an antihistamine (Olopatadine) with a steroid (Mometasone Furoate) for treatment of allergic rhinitis
In some countries such as France, Italy, Spain and the Balkan region, Menarini Group will lead the commercialisation effort, as part of an exclusive licensing agreement signed with Glenmark
Subscribe To Our Newsletter & Stay Updated
